Meningococcal conjugate vaccine Pregnancy and Breastfeeding Warnings
Medically reviewed by Drugs.com. Last updated on Jan 4, 2022.
Meningococcal conjugate vaccine is also known as: MenQuadfi, Menactra, Menveo
Meningococcal conjugate vaccine Pregnancy Warnings
Animal studies did not show treatment related effects on pregnancy or fetal development, parturition, or post-natal development. There are no controlled data in human pregnancy.
AU TGA pregnancy category B1: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have not shown evidence of an increased occurrence of fetal damage.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Use is recommended only if clearly needed and the benefit outweighs the risk.
AU TGA pregnancy category: B1
US FDA pregnancy category: C
Meningococcal conjugate vaccine Breastfeeding Warnings
Benefit should outweigh risk.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-It is considered unlikely that vaccinating a breast-feeding mother with this product would be harmful to the infant.
See also
References for pregnancy information
- "Product Information. Menactra (meningococcal conjugate vaccine)." sanofi pasteur (2005):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- Briggs GG, Yaffe SJ., Freeman RK "Drugs in Pregnancy and Lactation." Philadelphia, PA: Llippincott Williams & Wilkins (2011):
References for breastfeeding information
- "Product Information. Menactra (meningococcal conjugate vaccine)." sanofi pasteur (2005):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- Briggs GG, Yaffe SJ., Freeman RK "Drugs in Pregnancy and Lactation." Philadelphia, PA: Llippincott Williams & Wilkins (2011):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.